Completed
CLOFAImpact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in Agonist Triggered GnRH Antagonist in Vitro Fertilization Cycles. Phase IV, Single-centre, Open-label, Controlled Clinical Trial.
What is being tested
Clomifene Citrate
Drug
Who is being recruted
Urogenital Diseases+4
+ Genital Diseases
+ Female Urogenital Diseases and Pregnancy Complications
From 18 to 35 Years
+7 Eligibility Criteria
How is the trial designed
Phase 4
Interventional
Study Start: June 2012
Summary
Principal SponsorFundació Privada Eugin
Last updated: February 15, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: June 1, 2012
Actual date on which the first participant was enrolled.The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.
Principal SponsorFundació Privada Eugin
Last updated: February 15, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
10 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Female
Biological sex of participants that are eligible to enroll.From 18 to 35 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Urogenital DiseasesGenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsGenital Diseases, FemaleInfertilityFemale Urogenital DiseasesInfertility, Female
Criteria
5 inclusion criteria required to participate
18-35 years old
BMI 18-29 Kg/m2
No contraceptive pill
Normal basal hormonal levels
Show More Criteria
2 exclusion criteria prevent from participating
Polycystic ovarian syndrome (PCOS)
Previous participation in the study
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalClomifene Citrate 50 mg
Group II
No InterventionNo intervention
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center